Cargando…
Novel Roles of Amyloid-Beta Protein Precursor Metabolites in Fragile X Syndrome and Autism
Fragile X syndrome (FXS) is the most common form of inherited intellectual disability and is associated with up to 5% of autism cases. Several promising drugs are in preclinical testing for FXS; however, bench-to-bedside plans for the clinic are severely limited due to lack of validated biomarkers a...
Autores principales: | Westmark, Cara J., Sokol, Deborah K., Maloney, Bryan, Lahiri, Debomoy K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580495/ https://www.ncbi.nlm.nih.gov/pubmed/27573877 http://dx.doi.org/10.1038/mp.2016.134 |
Ejemplares similares
-
Novel Contribution of Secreted Amyloid-β Precursor Protein to White Matter Brain Enlargement in Autism Spectrum Disorder
por: Sokol, Deborah K., et al.
Publicado: (2019) -
APPlications of amyloid-β precursor protein metabolites in macrocephaly and autism spectrum disorder
por: Sokol, Deborah K., et al.
Publicado: (2023) -
Finding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissue
por: Ray, Balmiki, et al.
Publicado: (2016) -
FMRP Regulates the Nuclear Export of Adam9 and Psen1 mRNAs: Secondary Analysis of an N(6)-Methyladenosine Dataset
por: Westmark, Cara J., et al.
Publicado: (2020) -
Neurodevelopmental disorders and microcephaly: how apoptosis, the cell cycle, tau and amyloid-β precursor protein APPly
por: Sokol, Deborah K., et al.
Publicado: (2023)